share_log

Nxera Pharma Receives US$10 Million From AbbVie as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone

Nxera Pharma Receives US$10 Million From AbbVie as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone

Nxera Pharma收到艾伯維公司1億美元,因針對神經疾病的合作達成首個研發里程碑。
Sosei Group ·  06/26 11:00
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論